Switching From Consta® to Sustenna® in Patients With Schizophrenia

Risperdal Consta for Bipolar Disorder

NCT00177164 ·Status: COMPLETED ·Phase: PHASE3

A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.

NCT00094926 ·Status: COMPLETED ·Phase: PHASE3

Bioavailability of LY03004 and Risperdal® Consta®

NCT02091388 ·Status: COMPLETED ·Phase: PHASE1

A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

NCT00246259 ·Status: COMPLETED ·Phase: PHASE4

A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

NCT00216632 ·Status: COMPLETED ·Phase: PHASE4

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

NCT00246246 ·Status: COMPLETED ·Phase: PHASE3

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

NCT00246194 ·Status: COMPLETED

A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

NCT00297388 ·Status: COMPLETED ·Phase: PHASE3

An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone

NCT00246272 ·Status: COMPLETED ·Phase: PHASE3

Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia

NCT01451736 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia

NCT00249223 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia

NCT00253136 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

NCT00236353 ·Status: COMPLETED ·Phase: PHASE3

Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

NCT02411526 ·Status: COMPLETED ·Phase: PHASE1

Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

NCT00330551 ·Status: COMPLETED ·Phase: PHASE4

Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?

NCT00571688 ·Status: COMPLETED ·Phase: PHASE4

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

NCT00535132 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

NCT01894984 ·Status: TERMINATED

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

NCT00215579 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

NCT00299702 ·Status: COMPLETED ·Phase: PHASE4

A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate

NCT01682161 ·Status: COMPLETED ·Phase: PHASE4

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone

NCT00539071 ·Status: COMPLETED ·Phase: PHASE4

A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.

NCT00558298 ·Status: COMPLETED ·Phase: PHASE3

Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia

NCT00827840 ·Status: COMPLETED ·Phase: PHASE4

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

NCT00216476 ·Status: COMPLETED ·Phase: PHASE3